280 related articles for article (PubMed ID: 16254786)
1. The emergence of chemical genomics in drug discovery.
Zanders ED; Gordon RD; Gershater CJ
IDrugs; 2005 Nov; 8(11):919-23. PubMed ID: 16254786
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Discovery on Target 2006 - CHI's fourth annual event. Chemogenomics: small molecules as biological probes.
Murphy M
IDrugs; 2007 Jan; 10(1):30-2. PubMed ID: 17187311
[No Abstract] [Full Text] [Related]
4. Towards high-throughput characterization of small molecule mechanisms of action.
Luesch H
Mol Biosyst; 2006 Dec; 2(12):609-20. PubMed ID: 17216042
[TBL] [Abstract][Full Text] [Related]
5. Promises of biomarkers in drug development--a reality check.
Marrer E; Dieterle F
Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
[TBL] [Abstract][Full Text] [Related]
6. The ATCG of drug discovery.
Fernandes PB
Curr Opin Mol Ther; 2000 Dec; 2(6):624-32. PubMed ID: 11249739
[TBL] [Abstract][Full Text] [Related]
7. Proteomic methods for drug target discovery.
Sleno L; Emili A
Curr Opin Chem Biol; 2008 Feb; 12(1):46-54. PubMed ID: 18282485
[TBL] [Abstract][Full Text] [Related]
8. [Drug discovery based on genomic information].
Nohmi T
Rinsho Byori; 2002 Jul; 50(7):694-7. PubMed ID: 12187707
[TBL] [Abstract][Full Text] [Related]
9. Structural genomics and drug discovery: all in the family.
Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
[TBL] [Abstract][Full Text] [Related]
10. When will the genomics investment pay off for antibacterial discovery?
Mills SD
Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
[TBL] [Abstract][Full Text] [Related]
11. Chemogenomics: drug discovery's panacea?
Jacoby E
Mol Biosyst; 2006 May; 2(5):218-20. PubMed ID: 16880939
[TBL] [Abstract][Full Text] [Related]
12. From knowing to controlling: a path from genomics to drugs using small molecule probes.
Strausberg RL; Schreiber SL
Science; 2003 Apr; 300(5617):294-5. PubMed ID: 12690189
[TBL] [Abstract][Full Text] [Related]
13. Hit and Lead identification: efficient practices for drug discovery.
Goodnow RA; Gillespie P
Prog Med Chem; 2007; 45():1-61. PubMed ID: 17280901
[No Abstract] [Full Text] [Related]
14. High-throughput drug discovery: what can we expect from HTS?
Gribbon P; Sewing A
Drug Discov Today; 2005 Jan; 10(1):17-22. PubMed ID: 15676295
[No Abstract] [Full Text] [Related]
15. Hit and lead generation: beyond high-throughput screening.
Bleicher KH; Böhm HJ; Müller K; Alanine AI
Nat Rev Drug Discov; 2003 May; 2(5):369-78. PubMed ID: 12750740
[TBL] [Abstract][Full Text] [Related]
16. Drug discovery.
Kennedy D
Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461
[No Abstract] [Full Text] [Related]
17. The role of medicinal chemists in drug discovery.
Greenlee WJ; Desai MC
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):419-20. PubMed ID: 16022177
[No Abstract] [Full Text] [Related]
18. The chemical hunt for the identification of drugable targets.
Meisner NC; Hintersteiner M; Uhl V; Weidemann T; Schmied M; Gstach H; Auer M
Curr Opin Chem Biol; 2004 Aug; 8(4):424-31. PubMed ID: 15338571
[TBL] [Abstract][Full Text] [Related]
19. Integrating molecular design resources within modern drug discovery research: the Roche experience.
Stahl M; Guba W; Kansy M
Drug Discov Today; 2006 Apr; 11(7-8):326-33. PubMed ID: 16580974
[TBL] [Abstract][Full Text] [Related]
20. Seeing small molecules in action with bioorthogonal chemistry.
Raghavan AS; Hang HC
Drug Discov Today; 2009 Feb; 14(3-4):178-84. PubMed ID: 18973827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
